Alice Y. Zhou

Washington University in St. Louis — United States

Immunology and Microbiology · Life Sciences

23h-index4.6kcitations142works1.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immune Cell Function and Interaction(65), CAR-T cell therapy research(53), Immunotherapy and Immune Responses(17), Cancer Immunotherapy and Biomarkers(14), T-cell and B-cell Immunology(12)

Publications138 total

Supplementary Figure S6 from Memory-like Differentiation, Tumor-Targeting mAbs, and Chimeric Antigen Receptors Enhance Natural Killer Cell Responses to Head and Neck Cancer
2025Open Access
Supplementary Table S1 from Memory-like Differentiation, Tumor-Targeting mAbs, and Chimeric Antigen Receptors Enhance Natural Killer Cell Responses to Head and Neck Cancer
2025Open Access
Supplementary Figure S2 from Memory-like Differentiation, Tumor-Targeting mAbs, and Chimeric Antigen Receptors Enhance Natural Killer Cell Responses to Head and Neck Cancer
2025Open Access
Supplementary Figure S4 from Memory-like Differentiation, Tumor-Targeting mAbs, and Chimeric Antigen Receptors Enhance Natural Killer Cell Responses to Head and Neck Cancer
2025Open Access
Supplementary Figure S5 from Memory-like Differentiation, Tumor-Targeting mAbs, and Chimeric Antigen Receptors Enhance Natural Killer Cell Responses to Head and Neck Cancer
2025Open Access
Supplementary Figure S1 from Memory-like Differentiation, Tumor-Targeting mAbs, and Chimeric Antigen Receptors Enhance Natural Killer Cell Responses to Head and Neck Cancer
2025Open Access
Supplementary Figure S7 from Memory-like Differentiation, Tumor-Targeting mAbs, and Chimeric Antigen Receptors Enhance Natural Killer Cell Responses to Head and Neck Cancer
2025Open Access
Supplementary Figure S3 from Memory-like Differentiation, Tumor-Targeting mAbs, and Chimeric Antigen Receptors Enhance Natural Killer Cell Responses to Head and Neck Cancer
2025Open Access
599 The MATRiX trial: a multicenter, randomized, phase II study of ATR inhibition (via tuvusertib) with or without avelumab in patients with advanced anti-PD-(L)1-refractory merkel cell carcinoma
Regular and Young Investigator Award Abstracts·2025Open Access
Effect of frequency-dependent central thalamic stimulation in unconscious and comatose rats
Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition·2025
Eccrine carcinomas and homologous recombination repair cancer predisposition genes: A case series
JAAD Case Reports·2025Open Access
Circulating tumor DNA (ctDNA) dynamics during anti-PD-1 based therapy to predict clinical outcomes in advanced stage melanoma: A multicenter retrospective study.
Journal of Clinical Oncology·2025· 1 cited
Combination Strategies Enhance NK Cell Therapy for Multiple Myeloma (MM): Memory-like Differentiation, NKG2A Blockade, and Improved Recognition Via BCMA CAR or MM-Targeting Antibodies
Transplantation and Cellular Therapy·2025
Memory-like NK cell differentiation, inhibitory NKG2A blockade, and improved recognition via antibody or CAR engineering combine to enhance NK cell attack against multiple myeloma
The Journal of Immunology·2025· 4 citedOpen Access
Frequency-selective brain state regulation with optogenetic stimulation of central thalamus in unconscious rats
Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition·2024
CTIM-30. NT-I7, A LONG-ACTING INTERLEUKIN-7, PROMOTES ACTIVATION, CYTOTOXIC FUNCTION, AND SELECTIVE CLONOTYPE EXPANSION OF CD8+ T CELLS IN PATIENTS WITH HIGH GRADE GLIOMAS
Neuro-Oncology·2024Open Access
Associations between the Gut Microbiota and Sleep Disorder in Post-COVID-19 Patients Following Omicron Wave After Nearly 1-Year Recovery
2024Open Access
Figure 1 from Memory-like Differentiation Enhances NK Cell Responses to Melanoma
2024Open Access
Supplementary Fig S4 from Memory-like Differentiation Enhances NK Cell Responses to Melanoma
2024Open Access
Data from Memory-like Differentiation Enhances NK Cell Responses to Melanoma
2024Open Access
page 1 of 7Next →

Frequent Co-authors

Omar H. Butt(21), Todd A. Fehniger(13), George Ansstas(13), Jian Campian(11), Melissa M. Berrien-Elliott(11), Jennifer A. Foltz(11), Nancy D. Marín(11), David A. Russler‐Germain(10), Jennifer Tran(10), Pamela Wong(10), Celia C. Cubitt(10), Miriam T. Jacobs(10), Michelle Becker‐Hapak(10), Lynne Marsala(10), Keith Stockerl‐Goldstein(8), Patrick Pence(8), Toni K. Choueiri(7), Dimpy P. Shah(7), Michael A. Thompson(7), Ziad Bakouny(7)